Recent scientific findings explain why patients with a rare immunodeficiency disorder are unusually susceptible to certain common infections. By revealing the exact molecular mechanisms involved, they also give us clues as to why some ‘healthy’ people are more prone to these infections than others, and suggest potential treatments.
People with Hyper IgE Syndrome, or ‘Job’s Syndrome’, suffer from devastating Read the rest of this entry »
Archive for August 4, 2008
FDA on Thursday is expected to issue an advisory that urges physicians to conduct genetic testing before prescribing GlaxoSmithKline’s antiretroviral drug abacavir to reduce allergic reactions in people taking the drug, the New York Times reports. The recommendation to conduct genetic screenings will be included Read the rest of this entry »
When it comes to allergies, both the problem and the solution are found within us. Our immune systems respond to foreign substances with an arsenal of cells. Some are programmed to "remember" invaders they’ve encountered in the past. Normally, anything previously identified as harmless Read the rest of this entry »
Cytos Biotechnology Ltd (SWX:CYTN) announced
results from two randomized, double-blind, placebo-controlled,
multicentre phase II studies
with CYT003-QbG10 monotherapy for the treatment of house dust mite and cat
allergy, and with
CYT005-AllQbG10 combination therapy for the treatment of house dust mite
allergy. The studies were
conducted in order to determine whether QbG10 acts through an
allergen-independent Read the rest of this entry »